• Latest Posts

Alzheimer’s drugs could result from immune brain cell discovery

The six most advanced microbiome players aiming for the gut

Five latest advancements in Tourette’s syndrome research

DiogenX raises €27.5M for “breakthrough” diabetes treatment

Achilles Therapeutics’ new platform identifies most potent T-cell antigens

Cell and gene therapy company NewBiologix exits stealth with $50M

ADVERTISEMENT

5 highlights at first Genomics and Precision Medicine Expo

Scientists create first CRISPR-based drug candidate targeting the microbiome

Delivering on the need for vector innovation in genetic medicine

ADVERTISEMENT